Linked Life Data

9204227

Source:http://linkedlifedata.com/resource/pubmed/id/9204227

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-8-6
pubmed:abstractText
The focus of monitoring in diabetic pregnancy is no longer the prevention of fetal mortality, owing to the impressive benefits of strict maternal glucose control. Against this background, fetal monitoring must account for congenital anomalies, fetal mortality and severe morbidity as a result of metabolic consequences of hyperinsulinism, the exponential effect of diabetes when other maternal complications are present, and peripartum problems of the macrosomic infant, of delayed lung maturation, birth trauma and neonatal hypoglycemia. Thus, a broad range of potential fetal problems with varying maternal complications requires individualized, serial observation with multiple-format, properly validated tests. There has been recent progress: definition of the population at risk, clarification of pathophysiology, application of multiple-format tests, and evaluation of neonatal impacts; further precision may be developed with specific fetal tests. This review deals with the continued fine tuning of this critical area of perinatal medicine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1040-872X
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
83-90
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Fetal surveillance in diabetic pregnancy.
pubmed:affiliation
Fetal Assessment Unit, Women's Hospital, University of Manitobe, Canada.
pubmed:publicationType
Journal Article, Review